keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-Formyl-Met-Leu-Phe-Lys (fMLFK) (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.Chemotactic peptide (fMLFK) binds specifically to receptors on leukocyte membranes. Uptake of chemotactic peptides can contribute to quantitative assessment of neutrophils in localized inflammatory processes and is independent of associated edema formation or microcirculatory compromise.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 30,500 | |||
2 mg | 在庫あり | ¥ 45,500 | |||
5 mg | 在庫あり | ¥ 68,500 | |||
10 mg | 在庫あり | ¥ 104,000 | |||
25 mg | 在庫あり | ¥ 171,500 | |||
50 mg | 在庫あり | ¥ 241,000 | |||
100 mg | 在庫あり | ¥ 326,000 |
説明 | N-Formyl-Met-Leu-Phe-Lys (fMLFK) (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.Chemotactic peptide (fMLFK) binds specifically to receptors on leukocyte membranes. Uptake of chemotactic peptides can contribute to quantitative assessment of neutrophils in localized inflammatory processes and is independent of associated edema formation or microcirculatory compromise. |
ターゲット&IC50 | FPR1:3.5 nM (EC50), FPR2:6.7 μM (EC50), FPR2 (D2817.32G):0.88 μM (EC50) |
別名 | fMLFK |
分子量 | 565.73 |
分子式 | C27H43N5O6S |
CAS No. | 67247-11-4 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N-Formyl-Met-Leu-Phe-Lys 67247-11-4 Others Inhibitor fMLFK N Formyl Met Leu Phe Lys inhibit NFormylMetLeuPheLys inhibitor